Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
26,542,070
-
Share change
-
+1,264,124
-
Total reported value
-
$3,756,173,307
-
Put/Call ratio
-
211%
-
Price per share
-
$141.53
-
Number of holders
-
188
-
Value change
-
+$207,831,585
-
Number of buys
-
94
-
Number of sells
-
103
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2021
As of 30 Jun 2021,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,542,070 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, CPMG Inc, Invesco Ltd., VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, DEUTSCHE BANK AG\, and Duquesne Family Office LLC.
This page lists
188
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.